Octapharma
Financials
2023 Annual Revenue
€3.27 Billion
2023 Annual Gross Profit
€933.69 Million
2023 Annual Net Income
€354.24 Million
2023 Annual Revenue Growth
14.43%
2023 Number of Employees
11,908
Credit Rating
No Publicly Rated Debt
Octapharma
Octapharma Plasma is a wholly-owned subsidiary of Octapharma AG, one of the world’s largest makers of plasma products. Based in Lachen, Switzerland, Octapharma AG has been committed to patient care and medical innovation since 1983. They have biopharmaceutical experience around the world and employ more than 11,900 people globally. The financials presented are representative of the consolidated results of Octapharma AG, which is Octapharma Plasma's parent entity.